MYC and cancer: Therefore, successful inhibition of “undruggable” and yet major oncoproteins like Myc would constitute a critical step forward for the plausibility of modulating difficult transcription factor proteins, opening the door for the possibility to develop therapeutics for a wider range of cancers.